Navigation Links
Monitoring transfection efficiency by,,,green fluorescent protein (GFP) detection,,,with the Agilent 2100 bioanalyzer

This Application Note describes how the Agilent 2100 bioanalyzer and the Cell Fluorescence LabChip kit can be used to determine the efficiency of transfection of mammalian cells using green fluorescent protein (GFP) as a reporter molecule. Transfection of CHO-K1 cells with expression vectors encoding GFP from two different sources, and optimization of transfection conditions for both plasmids were performed. Histogram quality and the percent transfected cells determined, based on the low number of fluorescent cells counted with the microfluidic system, is in good agreement with data obtained with a conventional flow cytometer. Detailed protocols and reagent recommendations for analyzing transfection reactions are given. High reproducibility of chip results, low cell consumption and ease-of-use are advantages the compact Agilent 2100 bioanalyzer offers for monitoring transfection efficiency using GFP.
The Agilent 2100 bioanalyzer was introduced by Agilent Technologies as the first commercially available lab-on-a-chip analysis system for the life science laboratory using LabChipproducts, developed by Caliper Technologies Corp. Chip-based approaches for a variety of separation-based techniques have been introduced, addressing DNA, RNA, and protein separations. The Agilent 2100 bioanalyzer is capable of two-color fluorescence detection and runs disposable microfluidic glass chips. The application presented here is based on the controlled movement of cells through these channels by pressure-driven flow. Cells are hydrodynamically focused in the channels before passing the fluorescence detector in single file. Each chip accommodates several samples and data acquisition of all samples is fully automated while analysis allows for user-specific settings. Spec ific advantages of the instrument are the low number of cells required for analysis and the ease-of-use. Among the first applications investigated is the monitoring of cell transfection efficiency.
Transfection, the introduction of foreign DNA into a eukaryotic cell, is an important tool for studying the regulation of gene expression as well as protein expression and function. In stable transfection, the foreign DNA becomes integrated into the genomic DNA of the cell so that it is passed on in the cell lineage and continues to express the encoded gene of interest. More commonly used is transient transfection, in which higher copy numbers of the foreign DNA and hence higher levels of gene expression are present in the cell for a brief period of time. There are several methods available for cell transfection such as formation of complexes of the DNA with either DEAE dextran or calcium phosphate, to facilitate entry into the cell by endocytosis, or electroporation, which uses high voltage pulses to form transient pores in the cell membrane through which the DNA can enter. Currently, the most widely used method for transfecting cells is with cationic lipids that result in very high transfection efficiencies with low cytotoxicity.
In order to determine the percentage of cells in a transfection experiment that have received and are expressing the foreign DNA sequence, a reporter gene can be used. The reporter gene can be present on the same vector as the gene of interest or can be on a separate plasmid. The reporter gene can also be used to create a fusion protein with the gene of interest for protein localization studies. A convenient reporter for monitoring transfection efficiency is the green fluorescent protein (GFP). When excited by blue or UV light, the protein emits bright gre en fluorescence light through cyclization of a tripeptide chromophore embedded within the complete amino acid sequence. Genes encoding green fluorescent proteins have been cloned from various coelenterates such as the jellyfish Aequorea victoria and the sea pansy Renilla reniformis. To facilitate their use as reporters, several GFP variants have been developed by introducing amino acid substitutions into the chromophore, which result in a shift in the emission wavelength as well as an increase in fluorescence intensity. Additional mutations have been introduced to create preferred human codons in order to increase expression efficiency in mammalian cells. Many expression vectors containing these humanized GFP variants are commercially available. Expression of GFP is typically detected by fluorescence microscopy or flow cytometry.
In this Application Note, we describe the use of the Agilent 2100 bioanalyzer to monitor transfection efficiency using GFP as a reporter. CHO-K1 cells were transfected with GFP expression vectors using a cationic lipid reagent, and the percentage of GFP expressing cells within the live cell population was determined.
Cell Culture
CHO-K1 cells were obtained from ATCC and cultured in F12 medium containing 10 % FBS, 10 mM HEPES, Pen/Strep, 1 mM sodium pyruvate and 2 mM L-glutamine.
pEGFP-C2 (Clontech) and phrGFP (Stratagene) plasmid DNA was purified using the Perfectprep Plasmid XL kit (Eppendorf). Twenty hours before transfection, CHOK1 cells were seeded in a 6-well tissue culture plate at a density of 5 x 105 in 2 ml of growth medium and incubated overnight. On the day of transfection, 1 g of plasmid DNA was diluted into OPTIMEM (Life Technologies) and mixed with 6 l of Lipofectamine 2000 (Life Technologies) according to suppliers protocol. Prior to transfection, the growth medium was replaced with 2 ml of OPTIMEM. DNA-Lipofectamine complexes were added to the cells and incubated for 6 h. The transfection medium was then replaced by growth medium and cells were incubated for an additional 18 h.
Measuring transfection efficiency with the 2100 bioanalyzer
1. Cells were harvested and resuspended at 1x106 cells/ml in HBSS with 0.05 % pluronic acid (Molecular Probes). 2. Cells were stained with 0.5M of the live cell dye carboxynaphthofluorescein diacetate (CBNF, Molecular Probes) in the same buffer for 15 min at room temperature. 3. Afterwards, cells were washed in HBSS with 0.05 % pluronic acid. 4. Stained cells were centrifuged (500 x g, 5 minutes) and resuspended in cell buffer (supplied with the Cell Fluorescence LabChip kit) at 2 x 106 cells/ml 5. 10 l of the cell suspension was applied to the sample wells of the cell assay chip and analyzed on the Agilent 2100 bioanalyzer. Approximately 600-800 cell events were counted per sample. Parallel samples were prepared for conventional flow cytometer measurement. Cells were photographed on a Nikon fluorescence microscope.
Results and Discussion
For successful transfection of GFP plasmid DNA into CHO-K1 cells, the optimal DNA:lipid ratio was initially determined. As a result, 6 l of Lipofectamine 2000 was chosen as the optimal amount for transfection of 1 g of DNA in 6-well culture plates.
Assay of transfection efficiency on the 2100 bioanalyzer

In this experiment, pEGFP-C2, which encodes a red-shifted variant of wild-type Aeqourea GFP was used for transfection of CHOK1 cells. Mock- or EGFP- transfected cells were stained with the live cell dye CBNF and analyzed using the 2100 bioanalyzer. Approximately 600 cell events were collected for each sample. Figure 1A shows the dot plots of the fluorescence data (CBNF versus EGFP) of the control and EGFP-transfected cells. The population within the rectangular region represents live (CBNF-positive) and EGFPexpressing CHO-K1 cells. The data can also be displayed as frequency histograms, as depicted in figure 1B. In this case, in order to determine the percentage of EGFPexpressing cells, live cells in the CBNF-positive population were cross-gated onto the EGFP histogram. A parallel measurement of the same cell samples on a flow cytometer yielded a comparable result (figure 1C). On average, 600 to 800 cell events were collected for each sample run on the cell assay chip, whereas 10,000 events were collected using the flow cytometer. The histogram quality on both instruments was very similar (figure 1C). Figure 2 shows a photograph of the cell sample obtained with a fluorescence microscope.

Reproducibility of GFP transfection efficiency assay
To determine the reproducibility of the assay method using the 2100 bioanalyzer, the same mockor EGFP-transfected CHO-K1 cells were run on multiple cell assay chips. On each chip, mock-transfected cells were loaded in cell well 1 and EGFP-transfected cells in cell wells 2 to 6. Figure 3A shows the individual data points from 15 chips run on three different instruments (5 chips per instrument). Chip to chip reproducibility of the assay is shown in figure 3B. Figure 3C is a summary of the transfection data from 75 measurements of the same cell preparation assayed on the 2100 bioanalyzer. The transfection efficiency as determined on the 2100 bioanalyzer is identical to the result obtained usi ng a conventional flow cytometer.

Using the 2100 bioanalyzer to monitor optimization of transfection conditions
Measurement of the transfection efficiency and expression of GFP in cells are typically done by fluorescence microscopy or flow cytometry. Each of these methods has its drawbacks. Here we demonstrate that the 2100 bioanalyzer can be used to monitor quantitatively the expression of GFP in an exercise to develop an optimized transfection protocol for CHO-K1 cells. In the experiment, titration of Lipofectamine 2000 reagent was performed to determine the optimal DNA:lipid ratios that gave the best transfection efficiency in 6-well culture plates. In order to see if there are differences in transfection and expression levels of GFP from different species, reporter plasmids encoding green fluorescent proteins from Aequorea (EGFP) and Renilla (hrGFP) were used to transfect CHO-K1 cells. While keeping the amount of GFP (EGFP or hrGFP) plasmid DNA at 1 g, the DNA:lipid ratio was varied from 1 to 8 (ratios of 1, 2, 4, 6, and 8). Twenty hours after transfection, control cells and the 5 transfected cell samples were stained with CBNF and loaded into the wells of a cell assay chip and analyzed on the 2100 bioanalyzer. Figure 4 shows the results obtained when EGFP was used for transfection. At a DNA:lipid ratio of 1, expression of the reporter gene was barely detectable. There was a 20 to 25-fold enhancement in activity when the ratio was increased to 8. It indicated that optimal transfection and expression of EGFP were achieved when a DNA:lipid ratio of 6 or 8 was used. A comparable result was obtained when parallel cell samples were measured on a flow cytometer. The 2100 bioanalzyer results also correlated with the those obtained by fluorescence microscopy.

When CHO-K1 cells were transfected with phrGFP, which encodes a humanized Renilla GFP, there was a similar enhancement in transfection and expression of the reporter gene as the DNA:lipid ratio was increased from 1 to 8 (figure 5A). However, when compared to EGFP, the transfection efficiency of hrGFP was reduced (figure 5B) and the hrGFP-expressing population as a whole also showed a substantially diminished fluorescence intensity (figure 5C).

The Agilent 2100 bioanalyzer microfluidic lab-on-a-chip system can be used to monitor the transfection efficiency and expression of the GFP reporter gene in mammalian cells. It is particularly useful as a tool for optimization of transfection conditions for different transfection methods or new cell lines. In contrast to fluorescence microscope techniques, the 2100 bioanalyzer system provides accurate, quantitative data for optimization experiments, without tedious manual cell counting. The Agilent 2100 bioanalyzer is easy to use and requires a short setup time, while results for GFP expression are comparable to data obtained using conventional flow cytometry. The cell assay chip is disposable, can accommodate up to 6 samples, and requires as little as 20,000 cells per sample.



Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Versatile Reporter Vectors for Monitoring Viral Transduction
2. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
3. Monitoring Bacterial Genetic Diversity in a Freshwater Lake Using TTGE and DNA Sequence Analysis
4. Direct Monitoring of Solid-Phase Peptide Synthesis by MALDI-TOF MS
5. Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse
6. Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation
7. New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays
8. Outstanding transfection rates using the Multiporator
9. Outstanding transfection rates using the Multiporator
10. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
11. Confirming gene silencing mechanism by pGFP/GFP22 siRNA co-transfection
Post Your Comments:

(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):